UNSPSC 51152047: Suxethonium

This classification denotes a muscle relaxant with the molecular formula C16H34N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MED638SZQB, chemically known as succinic acid, diester with choline iodide but generally known as suxethonium, which bears US NIH Compound Identifier 71732. European Medicines Agency schedules Suxethonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15440MIG. The term SUXETHONIUM is an International Non-Proprietary Name.

As of Q4 2014, SUXETHONIUM remains the US FDA Preferred Term for this commodity. Suxethonium bears US NLM identifiers UMLS ID C0605824 and NCI Concept Code C87315. SMILES: CC[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)CC.[Cl-].

UNSPSC 51152047 Suxethonium is a Commodity code, but the single recent state and local opportunity in the dataset shows no activity related to suxethonium procurement. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking to procure naloxone and safe drug deactivation systems—products that fall outside the scope of this code's nominal pharmaceutical category. The mismatch suggests either a tagging error in the source data or that this code sees little relevant recent state and local procurement activity. No other opportunities appear in the dataset under this code.

Without substantive recent activity aligned to the code's actual scope, the geographic, issuing-body, and opportunity landscape cannot be characterized from the available source material. Business development professionals evaluating this code should verify the accuracy of its UNSPSC assignment and cross-reference related pharmaceutical or emergency-response commodity codes to identify actual state and local demand signals.